Literature DB >> 32816211

Perceived Barriers to Treatment in Persons Treated for Functional Gastrointestinal Disease with Constipation.

Klaus Bielefeldt1.   

Abstract

INTRODUCTION: Despite expanding treatment options, patients with functional gastrointestinal disorders (FGID) frequently express concerns about problems with access to care. We hypothesized that health insurance coverage contributes to the perceived problems with care delivery.
METHODS: Using the Medical Expenditure Panel Survey, we examined a cohort of participants defined by the diagnosis code for FGID plus the recorded prescription for laxative therapy. Demographic data, healthcare utilization and cost, insurance coverage, comorbid conditions, and information about provider characteristics were extracted for the years 2005-2015. Age- and sex-matched controls were identified for each year included. Barriers to care were based on responses to questions about inability to receive timely care or medication. Logistic regression was used to identify independent predictors of perceived barriers.
RESULTS: The cohort was female predominant (67.8%; mean age: 58.8 ± 0.33 years) with 15.4% reporting problems with access to care. Limited insurance coverage was most commonly cited by respondents. Consistent with this result, uninsured persons were significantly more likely to report barriers to care, while the type of insurance for those covered did not independently predict access problems. In addition, comorbidity burden and provider-specific factors, such as available contact options or insufficient explanations, correlated with perceived barriers to care delivery.
CONCLUSION: While the study design cannot establish causal links, persons with FGID commonly report access problems, which correlate with lack of health insurance and comorbidities. Providers can influence this perception by offering more flexible office hours and incorporating patient expectations related to treatment explanations and shared decision-making.

Entities:  

Keywords:  Access to care; Comorbidity; Cost of care; Irritable bowel syndrome; Satisfaction

Year:  2020        PMID: 32816211     DOI: 10.1007/s10620-020-06544-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis.

Authors:  Sari Hopson; Kim Saverno; Larry Z Liu; Ahmad AL-Sabbagh; John Orazem; Mary E Costantino; Margaret K Pasquale
Journal:  J Manag Care Spec Pharm       Date:  2015-12-14

2.  Out-of-pocket healthcare expenditure burdens among nonelderly adults with hypertension.

Authors:  Didem Minbay Bernard; Patrik Johansson; Zhengyi Fang
Journal:  Am J Manag Care       Date:  2014-05       Impact factor: 2.229

3.  Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.

Authors:  Jessica L Buono; Stavros Tourkodimitris; Phil Sarocco; Jeffrey M Johnston; Robyn T Carson
Journal:  Am Health Drug Benefits       Date:  2014-08

4.  Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.

Authors:  M E Flacco; L Manzoli; R De Giorgio; A Gasbarrini; A Cicchetti; F Bravi; M Altini; G P Caio; F Ursini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-04       Impact factor: 3.507

5.  Irritable bowel syndrome patients' ideal expectations and recent experiences with healthcare providers: a national survey.

Authors:  Albena Halpert; Christine B Dalton; Olafur Palsson; Carolyn Morris; Yuming Hu; Shrikant Bangdiwala; Jane Hankins; Nancy Norton; Douglas A Drossman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

6.  After-hours telephone calls in a family practice residency: volume, seriousness, and patient satisfaction.

Authors:  D L Greenhouse; J C Probst
Journal:  Fam Med       Date:  1995-09       Impact factor: 1.756

7.  Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome.

Authors:  Brian Lacy; Rajeev Ayyagari; Annie Guerin; Andrea Lopez; Sherry Shi; Michelle Luo
Journal:  Therap Adv Gastroenterol       Date:  2019-01-01       Impact factor: 4.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.